Works matching IS 13520504 AND DT 2020 AND VI 27 AND IP 5


Results: 14
    1
    2
    3

    Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 5, p. 497, doi. 10.1111/jvh.13261
    By:
    • Poordad, Fred;
    • Castro, RuiSarmento E.;
    • Asatryan, Armen;
    • Aguilar, Humberto;
    • Cacoub, Patrice;
    • Dieterich, Douglas;
    • Marinho, Rui Tato;
    • Carvalho, Armando;
    • Siddique, Asma;
    • Hu, Yiran Bonnie;
    • Charafeddine, Mariem;
    • Bondin, Mark;
    • Khan, Nader;
    • Cohen, Daniel E.;
    • Felizarta, Franco
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource‐limited settings.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 5, p. 466, doi. 10.1111/jvh.13244
    By:
    • Gane, Edward John;
    • Charlton, Michael R.;
    • Mohamed, Rosmawati;
    • Sollano, Jose Decena;
    • Tun, Kyaw Soe;
    • Pham, Thuy Thi Thu;
    • Payawal, Diana Alcantara;
    • Gani, Rino Alvani;
    • Muljono, David Handojo;
    • Acharya, Subrat Kumar;
    • Zhuang, Hui;
    • Shukla, Akash;
    • Madan, Kaushal;
    • Saraf, Neeraj;
    • Tyagi, Satyendra;
    • Singh, Karam Romeo;
    • Cua, Ian Homer Yee;
    • Jargalsaikhan, Ganbolor;
    • Duger, Davadoorj;
    • Sukeepaisarnjaroen, Wattana
    Publication type:
    Article
    14

    Issue Information.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 5, p. 463, doi. 10.1111/jvh.13138
    Publication type:
    Article